Citadel Advisors’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $776K | Buy |
|
|||||
|
2025
Q2 | $373K | Buy |
|
|||||
|
2025
Q1 | $67.2K | Sell |
|
|||||
|
2024
Q4 | $232K | Sell |
|
|||||
|
2024
Q3 | $1.76M | Buy |
|
|||||
|
2024
Q2 | $527K | Sell |
|
|||||
|
2024
Q1 | $5.64M | Buy |
|
|||||
|
2023
Q4 | $11.6K | Sell |
|
|||||
|
2023
Q3 | $3.78M | Buy |
|
|||||
|
2023
Q2 | $3.5M | Sell |
|
|||||
|
2023
Q1 | $7.55M | Buy |
|
|||||
|
2022
Q4 | $5.14M | Buy |
|
|||||
|
2022
Q3 | $2.82M | Buy |
|
|||||
|
2022
Q2 | $1M | Sell |
|
|||||
|
2022
Q1 | $2.63M | Buy |
|
|||||
|
2021
Q4 | $567K | Sell |
|
|||||
|
2021
Q3 | $3.43M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $7.87M | Buy |
|
|||||
|
2020
Q4 | $1.66M | Sell |
|
|||||
|
2020
Q3 | $13.3M | Sell |
|
|||||
|
2020
Q2 | $32.6M | Buy |
|
|||||
|
2020
Q1 | $200K | Buy |
|
|||||
|
2019
Q4 | $141K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $114K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $36K | Buy |
|
|||||
|
2016
Q2 | – | Hold |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $30K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $7K | Sell |
|
|||||
|
2015
Q1 | $83K | Buy |
|
|||||
|
2014
Q4 | $22K | Buy |
|
|||||
|
2014
Q3 | – | Hold |
|